等待开盘 02-05 09:30:00 美东时间
-8.180
-7.76%
FDA Submission Marks a Pivotal Milestone in Advancing Early Cancer Detection, Addressing Unmet Needs in Cancer Screening MENLO PARK, Calif., Jan. 29, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasda...
01-30 08:25
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02
Guggenheim analyst Subbu Nambi maintains GRAIL (NASDAQ:GRAL) with a Buy and raises the price target from $100 to $130.
01-27 00:36
U.S. stocks were higher, with the Dow Jones gaining around 200 points on Thursd...
01-22 23:13
MENLO PARK, Calif., Dec. 15, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company ...
2025-12-16 05:01
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
2025-12-03 09:58
Morgan Stanley analyst Tejas Savant maintains GRAIL (NASDAQ:GRAL) with a Equal-Weight and raises the price target from $85 to $110.
2025-12-03 01:39
MENLO PARK, Calif., Dec. 1, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has gr...
2025-12-02 05:01
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
2025-11-18 15:28
U.S. stocks were lower, with the Dow Jones index falling more than 100 points o...
2025-11-18 00:39